Cancer Control
Associations Between Glucagon-Like Peptide-1 Receptor Agonists (GLP-1RAs) and Cancer Risk: A Systematic Review and Meta-Analysis

Meta-analysis of observational studiesInterventions
Declared no competing interests
- GLP-1 receptor agonists
- GLP-1 and incretin signalling
- Colorectal cancer
- Endometrial cancer
- Esophageal cancer
- Humans
